Show simple item record

dc.contributor.authorBohnstedt, Catherine
dc.contributor.authorTaskinen, Mervi
dc.contributor.authorZeller, Bernward
dc.contributor.authorBjorgvinsdottir, Helga
dc.contributor.authorHafsteinsdottir, Solveig
dc.contributor.authorSchmiegelow, Kjeld
dc.date.accessioned2009-09-07T14:56:35Z
dc.date.available2009-09-07T14:56:35Z
dc.date.issued2009-01-01
dc.date.submitted2009-09-07
dc.identifier.citationJ. Pediatr. Hematol. Oncol. 2009, 31(1):79-80en
dc.identifier.issn1077-4114
dc.identifier.pmid19125098
dc.identifier.doi10.1097/MPH.0b013e31818b37a9
dc.identifier.urihttp://hdl.handle.net/2336/80131
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractNo abstract available
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen
dc.relation.urlhttp://dx.doi.org/10.1097/MPH.0b013e31818b37a9en
dc.subject.mesh6-Mercaptopurineen
dc.subject.meshAdolescenten
dc.subject.meshAntineoplastic Combined Chemotherapy Protocolsen
dc.subject.meshChilden
dc.subject.meshChild, Preschoolen
dc.subject.meshDown Syndromeen
dc.subject.meshFemaleen
dc.subject.meshGuideline Adherenceen
dc.subject.meshHumansen
dc.subject.meshInfanten
dc.subject.meshMaleen
dc.subject.meshMethotrexateen
dc.subject.meshNeoplasm Recurrence, Localen
dc.subject.meshPatient Complianceen
dc.subject.meshPhysician's Roleen
dc.subject.meshPrecursor Cell Lymphoblastic Leukemia-Lymphomaen
dc.subject.meshRandomized Controlled Trials as Topicen
dc.subject.meshSurvival Rateen
dc.subject.meshTreatment Outcomeen
dc.titlePoor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.en
dc.typeArticleen
dc.identifier.eissn1536-3678
dc.identifier.journalJournal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncologyen
html.description.abstractNo abstract available


This item appears in the following Collection(s)

Show simple item record